1
Particular attention should be given to opioid use in hospitalized children.
2
Findings fit negative reinforcement models associated with risk of developing opioid use disorder.
3
There were 191 subjects who met our criteria for probable problematic opioid use.
4
It also reviews the neurocognitive impact of pharmaceutical treatments for opioid use disorder.
5
Over this same period, monthly opioid use disorder diagnoses nearly tripled.
6
The increase in any opioid use was driven by long-term rather than short-term use.
7
However, prolonged opioid use can make a patient build up a tolerance to it.
8
Secondary outcomes included physical functioning, health-related quality of life, and reductions in opioid use.
9
Obesity, through its association with pain, may represent an important contributor to opioid use.
10
Educating patients and providers about negative reinforcement may help reduce opioid use and opioid-associated risks.
11
We examined the association of prescription size with new persistent opioid use after cardiothoracic surgery.
12
Spiegel is now starting a new trial to see if VR can actually reduce opioid use.
13
In women with opioid use disorder prenatal UDT results alone are insufficient to guide breastfeeding decisions.
14
However, the increase in opioid use during the nursing period has the potential for serious adverse effects.
15
We then examined demographics and substance use behaviors among parents with and without recent prescription opioid use.
16
New persistent opioid use is associated with the amount of opioid prescribed at the time of URS.
